EGIDs are serious, chronic, inflammatory digestive disorders that affect both children and adults. Lengthy diagnostic delays are common in EGIDs and they often result in disease progression and missed treatment opportunities.
In the upcoming virtual, interactive CME event, Eosinophilic GI Diseases Beyond the Esophagus: Where Have We Been and Where Are We Going?, Gary W. Falk, MD, MS, AGAF, Nirmala Gonsalves, MD, and Sandeep K. Gupta, MD, AGAF, will discuss the epidemiology, pathophysiology, clinical presentation and diagnosis of EGIDs. They will also review pharmacologic and nonpharmacologic treatments for EGIDs, including emerging therapies that target specific inflammatory cytokines and cells implicated in EGID pathogenesis and progression.
Join them on Tuesday, Aug. 11, at 7 p.m. EDT to:
- Increase your knowledge regarding the pathogenesis of EGIDs, steps for diagnosis of EGIDs and clinical data on emerging therapies for EGIDs.
- Gain greater competence related to selecting treatments for patients with EGIDs.
The program is presented through a collaboration between AGA and Medscape Education. It is supported by an educational grant from Allakos. It offers 1.50 AMA PRA Category 1 Credit(s)™.
